Yale University

Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.

TitleCorrelates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.
Publication TypeJournal Article
Year of Publication2015
AuthorsSpringer, Sandra A., Shan-Estelle Brown, and Angela Di Paola
JournalDrug and alcohol dependence
Date Published2015 Oct 28
ISSN1879-0046
AbstractThe acceptability of and retention on extended-release naltrexone (XR-NTX), an FDA-approved medication for the treatment of alcohol and opioid use disorders, among persons living with HIV disease (PLH) under criminal justice setting (CJS) supervision has not been evaluated to date.
DOI10.1016/j.drugalcdep.2015.10.023
Alternate JournalDrug Alcohol Depend

External Links